Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Investor Spotlight: Golden Pine Ventures

January 3rd, 2008

Investor Spotlight: Golden Pine Ventures

Abstract:
Golden Pine Ventures, founded in the summer of 2004, has not disclosed the size of its fund, but Meldrum says it has enough to do between six and eight investments in the early-stage biotechnology and biomedical companies it favors.

Meldrum says the firm's typical investment depends on the opportunity, but has invested $100,000 in a couple. "We're looking at opportunities where we want to get to proof of concept," he says.

As an example, he cites the firm's only non-Southeastern investment in Kylin, which employs a revolutionary RNA nanoparticle technology platform called "pRNA" to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases.

Source:
techjournalsouth.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New class of protein misfolding simulated in high definition: Evidence for recently identified and long-lasting type of protein misfolding bolstered by atomic-scale simulations and new experiments August 8th, 2025

Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025

Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025

Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Nanomedicine

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

New imaging approach transforms study of bacterial biofilms August 8th, 2025

Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025

First real-time observation of two-dimensional melting process: Researchers at Mainz University unveil new insights into magnetic vortex structures August 8th, 2025

Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project